Cargando…
7.3 Successful use of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334169/ http://dx.doi.org/10.1186/1546-0096-6-S1-S13 |
| _version_ | 1782230605447036928 |
|---|---|
| author | Miettunen, PM Jayanthan, A Narendran, A |
| author_facet | Miettunen, PM Jayanthan, A Narendran, A |
| author_sort | Miettunen, PM |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3334169 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2008 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-33341692012-04-24 7.3 Successful use of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis Miettunen, PM Jayanthan, A Narendran, A Pediatr Rheumatol Online J Oral Presentation BioMed Central 2008-09-15 /pmc/articles/PMC3334169/ http://dx.doi.org/10.1186/1546-0096-6-S1-S13 Text en Copyright ©2008 Miettunen et al; licensee BioMed Central Ltd. |
| spellingShingle | Oral Presentation Miettunen, PM Jayanthan, A Narendran, A 7.3 Successful use of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis |
| title | 7.3 Successful use of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis |
| title_full | 7.3 Successful use of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis |
| title_fullStr | 7.3 Successful use of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis |
| title_full_unstemmed | 7.3 Successful use of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis |
| title_short | 7.3 Successful use of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis |
| title_sort | 7.3 successful use of anakinra, a soluble il-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334169/ http://dx.doi.org/10.1186/1546-0096-6-S1-S13 |
| work_keys_str_mv | AT miettunenpm 73successfuluseofanakinraasolubleil1receptorantagonistinpediatricrheumaticdiseasesassociatedmacrophageactivationsyndromereactivehemophagocyticlymphohistiocytosis AT jayanthana 73successfuluseofanakinraasolubleil1receptorantagonistinpediatricrheumaticdiseasesassociatedmacrophageactivationsyndromereactivehemophagocyticlymphohistiocytosis AT narendrana 73successfuluseofanakinraasolubleil1receptorantagonistinpediatricrheumaticdiseasesassociatedmacrophageactivationsyndromereactivehemophagocyticlymphohistiocytosis |